Helping people with communication difficulties after stroke to understand warfarin therapy

Similar documents
Warfarin Atrial Fibrillation Consultations A Visual Support Tool

Atrial Fibrillation and Anticoagulants


Guidelines for slow loading of patients on warfarin for Atrial Fibrillation (AF) in the non acute setting

Pulmonary Embolism (PE)

Tackling atrial fibrillation the health economics evidence

Thrombosis and Anticoagulation Team. Warfarin. Information for patients, relatives and carers

pat hways Key therapeutic topic Published: 26 February 2016 nice.org.uk/guidance/ktt16

Novel oral anticoagulant therapy (NOAC)

Atrial fibrillation and anticoagulation therapy

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Single Technology Appraisal (STA)

A review of aphasia. Katrina Clarkson Principal Speech and Language Therapist, Regional Rehabilitation Unit, Northwick Park Hospital

References: Murtagh J. Murtagh s General Practice. 5 th edn. Sydney: McGraw Hill; 2010.

The first stop for professional medicines advice. Community Pharmacy Oral Anticoagulant Safety Audit

AN AUDIT: THROMBOPROPHYLAXIS FOR TOTAL HIP REPLACEMENT PATIENTS AT NORTHWICK PARK AND CENTRAL MIDDLESEX HOSPITALS

Cerebral Venous Thrombosis (CVT)

Patient Sticky Label. A Resource Guide for Stroke Survivors and their Caregivers

Warfarin. Information for patients taking warfarin

Living with a New Oral Anticoagulant (NOAC)

Location of initiative York Region Chronic Kidney Disease Program, Mackenzie Richmond Hill Hospital, Richmond Hill, ON

What is aphasia? Katrina Clarkson Principal Speech and Language Therapist, Regional Rehabilitation Unit, Northwick Park Hospital

Direct Oral Anticoagulant (DOAC)Therapy. Important information for patients prescribed: Apixaban, Dabigatran, Edoxaban or Rivaroxaban

Anticoagulation in Atrial Fibrillation Patient information

Atrial Fibrillation Implementation challenges. Lesley Edgar Ross Maconachie

Adherence to VKA treatments : What are the needs?

CARDIAC REHABILITATION PROGRAMME:- MEDICATION

Surgery for Patients on Oral Anticoagulants

Warfarin PATIENT EDUCATION

DOAC support programme. engage supported self-care

DIRECT ORAL ANTICOAGULANTS: WHEN TO USE, WHICH TO CHOOSE AND MANAGEMENT OF BLEEDING

Are There Any Special Instructions When Taking Warfarin

Treatment with Rivaroxaban Xarelto

Anticoagulant treatment for DVT

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Single Technology Appraisal (STA)

Rivaroxaban film coated tablets are available in 2 strengths for this indication: 15mg and 20mg.

Things to Know When Taking Warfarin (Coumadin ) Anticoagulation Therapy

Atrial fibrillation. Understanding NICE guidance

Helping to prevent stroke caused by non-valvular atrial fibrillation Information booklet

DRUG NAME: EDOXABAN (LIXIANA ) Transfer of Care document Treatment of acute venous thromboembolism and prevention of recurrent venous thromboembolism

Primary Care Prescriber Information EDOXABAN (LIXIANA ) Treatment of acute venous thromboembolism and prevention of recurrent venous thromboembolism

Pradaxa. [dabigatran etexilate] patient support booklet

Imaging Department Investigative procedure information leaflet Percutaneous biopsy of Lung (CT guided)

NOACS/DOACS*: COMPARISON AND FREQUENTLY-ASKED QUESTIONS

Atrial fibrillation patient decision aid: Antithrombotic therapy

Adjusting the way to speak when communicating with people who have visual impairment and additional needs

Olanzapine Long-Acting Injection (Zypadhera ) - Guidelines for Prescribing and Administration (Version 3 May 2015)

Clinical Guide - Patient Information (January 2007)

To prevent blood clots after hip or knee replacement surgery This booklet contains information for those who have been prescribed ELIQUIS (apixaban)

CLINICAL PROTOCOL THE PREVENTION OF FATALITIES FROM MEDICATION LOADING DOSES

Management of haemorrhage in patients taking DOACs/ NOACs (direct/ novel oral anticoagulants) Guideline. Contents

The Neuro-rehabilitation enhanced transition team (NETT)

NEW/NOVEL ORAL ANTICOAGULANTS (NOACS): COMPARISON AND FREQUENTLY ASKED QUESTIONS

CLINICAL PROTOCOL THE PREVENTION OF FATALITIES FROM MEDICATION LOADING DOSES

NOAC Prescribing in Patients with Non-Valvular Atrial Fibrillation: Frequently Asked Questions

Direct Current Cardioversion (DCCV)

Treatment with Apixaban Eliquis

INTRODUCTION Indication and Licensing

Improving medication safety

Local steroid injections to joints and soft tissues

WARFARIN ANTICOAGULANT RECORD

bpac better e m dicine

Cervical cancer screening event summary

GRASP-AF- The National Picture. Dr Richard Healicon National Improvement Lead Ian Robson Senior Analyst NHS Improvement February 2012

Use of unlicensed medicines and off-label uses

Community Pharmacy Safety in Practice Warfarin Change Package 2017

AF A. The reality of life on Anticoagulation therapy. A report by the Atrial Fibrillation Association and AntiCoagulation Europe

NHS Lanarkshire Care Homes Protocol Group. Warfarin Guidance and Administration Record for Care Homes

ADDRESSING UNMET NEEDS IN MANAGING AF ACROSS THE GLOBE

Primary Care Prescriber Information RIVAROXABAN (XARELTO ) Prevention of stroke and embolism for nonvalvular atrial fibrillation

Show Me the Outcomes!

Policy for the safe use of oral methotrexate

Primary Care Prescriber Information EDOXABAN (LIXIANA ) Prevention of stroke and embolism for nonvalvular atrial fibrillation

Tacrolimus. Information for patients about using the drug Tacrolimus.

Robotic-assisted lingual tonsillectomy for sleep apnoea

UW MEDICINE PATIENT EDUCATION. Treating Blood Clots. What is a blood clot? DRAFT

Apixaban for stroke prevention in atrial fibrillation. August 2010

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Single Technology Appraisal (STA)

18/09/2012. Dr. Khalid Khan Consultant Cardiologist BCUHB. Oral Anticoagulation Update Day 12 th September 2012 University of Birmingham

Edoxaban Switch Programme - Frequently Asked Questions

Methotrexate for inflammatory bowel disease: what you need to know

Medicines for stroke prevention in atrial fibrillation. Choosing the right one for you

Treatment of deep vein thrombosis and pulmonary embolism with low molecular weight heparin

Aim. Managing high risk medicines in primary care. Intended outcomes. Introduction. Risk associated with prescribing

This booklet has been provided to help answer some of the questions you may have about RFA of liver tumours.

easy read Your rights under THE accessible InformatioN STandard

Amiodarone Therapy. Exceptional healthcare, personally delivered

2 Summary of NICE TA 249: Atrial fibrillation - Dabigatran Etexilate

NHS Lanarkshire Guidance on Anticoagulant treatment for patients with non-valvular atrial fibrillation

Blood-thinning medication after stroke

Steps Against Recurrent Stroke (STARS)

Managing low-risk basal cell carcinomas in the community

Physical Activity and Heart Failure:

Patient Information. Acute Kidney Injury (AKI)

PULL OUT AND KEEP THIS CPD MODULE PLUS PRE-TEST AND POST-TEST IS ONLINE AT PHARMACYMAGAZINE.CO.UK PHARMACY MAGAZINE

Oral N-Acetyl CystieneTablets. Patient Information

Rivaroxaban. medication do? Xarelto. is a blood. Medication. Emboli (PE).

Treating atrial fibrillation using heat energy delivered to the outside of the heart through a thin tube

Breast Cancer and Breast Screening

Olanzapine Long Acting Injection (LAI) Guideline

Anticoagulation Task Force

Transcription:

Helping people with communication difficulties after stroke to understand warfarin therapy Satinder Bhandal, Consultant Anticoagulation Pharmacist, Buckinghamshire Healthcare Trust and UK Clinical Pharmacy Association Nina Barnett Consultant pharmacist, Older People, Medicines Use and Safety Division, NHS Specialist Pharmacy Service Katrina Clarkson Principal Speech and Language Therapist, London North West Healthcare NHS Trust

What is aphasia? Loss or impairment of language function caused by brain damage Aphasia is a multimodal disorder: Difficulties in speaking, understanding, reading, writing Reduction in capacity to interpret and formulate linguistic elements (e.g. sentences, words, morphemes the smallest grammatical unit in a language) Murdoch (2010)

Who experiences aphasia? People who have had a stroke Brain tumour (primary or secondary) Traumatic head injury Hypoxic brain injury

Who needs anticoagulation Stroke - AF Other reasons Deep Vein Thrombosis Pulmonary Embolus Mechanical heart value Pulmonary hypertension Severe cardiomyopathy

Atrial Fibrillation some facts Prevalence - 1.7% in England in 2012/13 Incidence of stroke attributable to AF is 1.5% in those aged 50 to 59 years It rises to 23.5% for between 80 and 89 years Counselling elderly patients many with multiple co-morbidities, polypharmacy and reduced cognition challenging In addition some of those will already have suffered a stroke which may result in preexisting aphasia

Which anticoagulant? Warfarin Advantages of warfarin Tried and tested well tolerated easy to monitor adherence keeps you connected with health system More experience in reversing and antidote available Disadvantages of warfarin Complex dosing regimen Slow onset Frequent monitoring trips Drugs and food interaction

What about DOACs (direct oral anticoagulants)? Advantages of DOACs Simple dosing regimens fast acting (vs warfarin can take ages to get to an effective level) less drug and food interaction less treatment burden (convenience) Some DOACs can be put in compliance aids Disavantages DOAC less well tolerated (eg one in five people stop after 2 year, rash, headache, fuzziness, GI side effect (diarrhoea can be disabling) Other than dabigatran, no licenced antidote

NPSA 2006 Anticoagulant risk assessment Several participants with strokes stressed the need for doctors to give appropriate time to patients with aphasia to ensure that they properly understood their medication. You WILL need extra time to counsel the patient with aphasia So, a new tool may help...

What do we use now? Anticoagulation therapy Pack ( yellow book ) Patient information booklet Alert card for patient Record of INR book Treatment sheets

What do we need to communicate effectively to patient with aphasia? Short message Clear sentences Easy words Good layout Diagrams and pictures Appropriate font

What did we create Learning event with pharmacist and speech and language therapist Agreed on simple, accessible, online tool which can be downloaded for local use Powerpoint slides using SLT guidance for presentation and pharmacist guidance for content For example..

Yellow book - warfarin doses

Your new tablet is Warfarin The tablets are 1mg 3mg 5mg different strengths Bucks Healthcare & NHS Specialist Pharmacy Service 2015

Take Warfarin once a day When will you remember to take it? Bucks Healthcare & NHS Specialist Pharmacy Service 2015

Yellow book - INR

You will need regular blood tests The test is INR It shows how much warfarin you need If you are ill you need an extra blood test that week Bucks Healthcare & NHS Specialist Pharmacy Service 2015

Yellow book dietary interactions

Foods All foods are okay Keep what you eat the same each week Bucks Healthcare & NHS Specialist Pharmacy Service 2015

Yellow book - alcohol

Do not drink lots of alcohol Keep what you drink the same each week Bucks Healthcare & NHS Specialist Pharmacy Service 2015

Summary for healthcare professionals Blood tests (INR) Take Warfarin every day No big changes to diet No binge alcohol If very ill get extra blood test that week Tell family and health professionals you are on Warfarin Bucks Healthcare & NHS Specialist Pharmacy Service 2015

Where can you get a copy? Tool freely available to download https://www.sps.nhs.uk/articles/warfarin-consultation-for-patients-with-aphasia/ Now includes DOACs Bucks Healthcare & NHS Specialist Pharmacy Service 2015

Acknowledgements Satinder Bhandal, Consultant pharmacist Anticoagulation, Buckinghamshire Healthcare NHS. Trust Frances Akor, Consultant Pharmacist Anticoagulation, Imperial College Healthcare NHS Trust. Katrina Clarkson, Principal Speech and Language Therapist, Regional Hyperacute Rehabilitation Unit, Northwick Park Hospital, Clare Cahoon, Highly Specialist Speech and Language Therapist, Regional Hyperacute Rehabilitation Unit, Northwick Park Hospital, Nina Barnett Consultant Pharmacist, Older People, Medicines Use and Safety Division, NHS Specialist Pharmacy Service and London North West Healthcare NHS Trust With thanks to the UKCPA HAT group, Estelle Bloom at Making It Clear and the patients of Bucks Healthcare Trust. Bucks Healthcare and Medicines Use and Safety Division, NHS Specialist Pharmacy Service 2015